WASHINGTON, May 23: Scientists and pharmaceutical companies are increasingly using artificial intelligence systems to accelerate drug discovery and medical research.
Experts believe AI-driven analysis could significantly reduce the time required to identify potential treatments for complex diseases, including rare disorders and chronic illnesses.